Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
BG Medicine, Inc. (NASDAQ: BGMD) shares soared 31.21 percent to close at $1.85 a share Tuesday. The stock traded between $1.46 and $1.87 on volume 9.32 million shares traded. The company is scheduled to release fiscal year 2013 financial results before market open on Thursday, March 20th. Shares of BG Medicine are up approximately 77.0 percent year-to-date.
Get more information on BG Medicine free access to the in-depth equity report at:
Flamel Technologies S.A. (NASDAQ: FLML) shares spiked 18.40 percent to close at $13.19 a share Tuesday. The stock traded between $11.55 and $13.29 on volume 694,188 shares traded. The company is scheduled to release fourth quarter and fiscal year 2013 results before market open on Tuesday, March 25th. Shares of Flamel Technologies are up approximately 66.0 percent year-to-date.
Get more information on Flamel Technologies and free access to the in-depth equity report at:
Metabolix, Inc. (NASDAQ: MBLX) shares jumped 13.67 percent to close at $1.58 a share Tuesday. The stock traded between $1.41 and $1.67 on volume of 891,367 shares traded. The company is scheduled to release fourth quarter fiscal year 2013 results after market close on Thursday, March 27th. Shares of Metabolix are up approximately 25.0 percent year-to-date.
Get more information on Metabolix and free access to the in-depth equity report at:
Penn Virginia Corporation (NYSE: PVA) shares surged 15.58 percent to close at $15.73 a share Tuesday. The stock traded between $13.57 and $16.00 on volume of 8.80 million shares traded. Soros Fund Management has recently disclosed it has taken a 9.18 percent active stake in the company. Shares of Penn Virginia are up approximately 66.0 percent year-to-date.
Get more information on Penn Virginia and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities